This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Rye Brook, NY, Xylem Inc. is one of the leading providers of water solutions worldwide. The company is involved in the full water-process cycle, including collection, distribution and returning of water to the environment. It has significant presence in the United States, the Asia Pacific, Europe and various other nations. The company reports business operations under three segmental heads — Water Infrastructure, Sensus and Applied Water.
Stanley Black (SWK) Q4 Earnings Beat, Down Y/Y on Supply Woes
by Zacks Equity Research
Stanley Black's (SWK) Q4 earnings reflect the impacts of buyout synergies, favorable pricing, lower volumes and cost inflation. It predicts year-over-year growth in earnings per share for 2022.
Will High Demand & Supply Woes Impact Xylem's (XYL) Q4 Earnings?
by Zacks Equity Research
Xylem's (XYL) Q4 results are likely to reflect gains from strengthening demand in end markets and operational execution. Inflationary pressure and supply-chain restrictions might have weighed on it.
Graco (GGG) Beats on Q4 Earnings & Sales, Faces Cost Woes
by Zacks Equity Research
Graco's (GGG) Q4 earnings reflect gains from solid segmental and regional results. Cost inflation and supply-chain woes impact margins. It projects organic sales growth for 2022.
Earnings Preview: Xylem (XYL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) & Isle to Lower Carbon Footprint in Water Systems
by Zacks Equity Research
Xylem's (XYL) partnership with Isle Utilities will help the technology innovators and water utilities execute advanced technology deployments in water systems.
Xylem (XYL) Exhibits Strong Prospects, Headwinds Persist
by Zacks Equity Research
Xylem (XYL) stands to gain from solid demand for its products, focus on innovation, healthy backlog level and shareholder-friendly policies. Rising costs and expenses and high debt level are concerns.
Why Is Xylem (XYL) Down 5.6% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Xylem (XYL) Surpasses Q3 Earnings Estimates, Lowers View
by Zacks Equity Research
Xylem's (XYL) Q3 earnings reflect the impacts of healthy demand in Water Infrastructure and Applied Water segments as well as supply-chain woes. It lowers its 2021 projections.
Xylem (XYL) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 6.78% and -1.12%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Supply-Chain, Cost Woes to Influence Xylem's (XYL) Q3 Earnings
by Zacks Equity Research
Xylem's (XYL) Q3 results are likely to reflect the impacts of restricted availability of electronic components and cost inflation. Contract wins, product offerings and end markets are likely to have aided.
Earnings Preview: Xylem (XYL) Q3 Earnings Expected to Decline
by Zacks Equity Research
Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) and Dragos to Provide Cybersecurity Solutions
by Zacks Equity Research
Xylem's (XYL) partnership with Dragos will enable it to offer co-branded incident response and incident prevention services to customers in the water utility sector.
Xylem (XYL) Provides Long-Term View, Updates '21 Projections
by Zacks Equity Research
Xylem (XYL) at the Analyst Day discusses long-term growth strategies and financial framework. For the second half of 2021, it expects $100 million of adverse sales impacts from supply-chain headwinds.
MNTX or XYL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MNTX vs. XYL: Which Stock Is the Better Value Option?
Why Is Xylem (XYL) Up 7.8% Since Last Earnings Report?
by Zacks Equity Research
Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MNTX vs. XYL: Which Stock Is the Better Value Option?
by Zacks Equity Research
MNTX vs. XYL: Which Stock Is the Better Value Option?
Xylem (XYL) Tops on Q2 Earnings & Revenues, Hikes '21 View
by Zacks Equity Research
Xylem's (XYL) Q2 earnings increase year over year on strengthening segmental businesses and margin improvement. It hikes projections for organic sales growth and the low-end of 2021 earnings.
Xylem (XYL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Xylem (XYL) delivered earnings and revenue surprises of 4.76% and 2.88%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks' Aug 3 Q2 Earnings Roster: SEE, ETN & More
by Madhurima Das
A sneak peek at how industrial stocks Sealed Air Corporation (SEE), Eaton Corporation, PLC (ETN), Zebra Technologies Corporation (ZBRA) and Xylem Inc. (XYL) are likely fare in their Q2 results.
Xylem (XYL) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Xylem's (XYL) Q2 earnings are likely to have gained from strength across its businesses, strong backlog level and focus on operational execution. Woes related to cost inflation might have affected it.
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Xylem (XYL) is a Strong Momentum Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights include: CarMax, Crown Holdings, CenterPoint Energy, Nutrien and Xylem
by Zacks Equity Research
Zacks.com featured highlights include: CarMax, Crown Holdings, CenterPoint Energy, Nutrien and Xylem
5 Stocks With Upbeat Sales Growth Worth Betting on Right Now
by Swayta Shah
Sales growth is crucial for the survival of any business. Let's check out CarMax (KMX), Crown Holdings (CCK), CenterPoint Energy (CNP), Nutrien (NTR) and Xylem (XYL) that are likely to record robust sales growth.
The Zacks Analyst Blog Highlights: Emerson Electric, Deere, Caterpillar, Xylem and Parker-Hannifin Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Emerson Electric, Deere, Caterpillar, Xylem and Parker-Hannifin Corp